Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 29% ± 16% | |
squamous epithelial cell | 4 studies | 37% ± 19% |
Insufficient scRNA-seq data for expression of PTK6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 69% | 1229.37 | 248 / 359 | 94% | 63.53 | 270 / 286 |
bladder | 52% | 1282.05 | 11 / 21 | 92% | 82.08 | 465 / 504 |
intestine | 42% | 1965.00 | 409 / 966 | 97% | 75.88 | 510 / 527 |
esophagus | 39% | 4792.92 | 568 / 1445 | 90% | 48.85 | 164 / 183 |
pancreas | 15% | 120.98 | 49 / 328 | 90% | 64.15 | 160 / 178 |
lung | 22% | 150.53 | 127 / 578 | 82% | 32.65 | 946 / 1155 |
breast | 18% | 173.22 | 83 / 459 | 84% | 26.94 | 939 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.09 | 1 / 1 |
skin | 72% | 4907.06 | 1304 / 1809 | 22% | 4.32 | 106 / 472 |
tonsil | 0% | 0 | 0 / 0 | 87% | 30.03 | 39 / 45 |
prostate | 23% | 311.27 | 56 / 245 | 57% | 16.85 | 286 / 502 |
uterus | 2% | 102.58 | 4 / 170 | 69% | 40.30 | 317 / 459 |
liver | 23% | 204.26 | 53 / 226 | 27% | 7.21 | 111 / 406 |
ovary | 0% | 0 | 0 / 180 | 26% | 4.49 | 111 / 430 |
adrenal gland | 0% | 0 | 0 / 258 | 25% | 3.70 | 58 / 230 |
kidney | 0% | 0 | 0 / 89 | 7% | 1.78 | 63 / 901 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.79 | 2 / 29 |
brain | 1% | 9.41 | 38 / 2642 | 3% | 0.38 | 24 / 705 |
eye | 0% | 0 | 0 / 0 | 3% | 0.22 | 2 / 80 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.20 | 7 / 605 |
adipose | 0% | 6.89 | 5 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.11 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.69 | 2 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.22 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0007260 | Biological process | tyrosine phosphorylation of STAT protein |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0045087 | Biological process | innate immune response |
GO_0038128 | Biological process | ERBB2 signaling pathway |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0030154 | Biological process | cell differentiation |
GO_0061099 | Biological process | negative regulation of protein tyrosine kinase activity |
GO_0006468 | Biological process | protein phosphorylation |
GO_0060575 | Biological process | intestinal epithelial cell differentiation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0045926 | Biological process | negative regulation of growth |
GO_0016477 | Biological process | cell migration |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0001726 | Cellular component | ruffle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PTK6 |
Protein name | Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) |
Synonyms | BRK |
Description | FUNCTION: Non-receptor tyrosine-protein kinase implicated in the regulation of a variety of signaling pathways that control the differentiation and maintenance of normal epithelia, as well as tumor growth. Function seems to be context dependent and differ depending on cell type, as well as its intracellular localization. A number of potential nuclear and cytoplasmic substrates have been identified. These include the RNA-binding proteins: KHDRBS1/SAM68, KHDRBS2/SLM1, KHDRBS3/SLM2 and SFPQ/PSF; transcription factors: STAT3 and STAT5A/B and a variety of signaling molecules: ARHGAP35/p190RhoGAP, PXN/paxillin, BTK/ATK, STAP2/BKS. Associates also with a variety of proteins that are likely upstream of PTK6 in various signaling pathways, or for which PTK6 may play an adapter-like role. These proteins include ADAM15, EGFR, ERBB2, ERBB3 and IRS4. In normal or non-tumorigenic tissues, PTK6 promotes cellular differentiation and apoptosis. In tumors PTK6 contributes to cancer progression by sensitizing cells to mitogenic signals and enhancing proliferation, anchorage-independent survival and migration/invasion. Association with EGFR, ERBB2, ERBB3 may contribute to mammary tumor development and growth through enhancement of EGF-induced signaling via BTK/AKT and PI3 kinase. Contributes to migration and proliferation by contributing to EGF-mediated phosphorylation of ARHGAP35/p190RhoGAP, which promotes association with RASA1/p120RasGAP, inactivating RhoA while activating RAS. EGF stimulation resulted in phosphorylation of PNX/Paxillin by PTK6 and activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. PTK6 activates STAT3 and STAT5B to promote proliferation. Nuclear PTK6 may be important for regulating growth in normal epithelia, while cytoplasmic PTK6 might activate oncogenic signaling pathways.; FUNCTION: Isoform 2 inhibits PTK6 phosphorylation and PTK6 association with other tyrosine-phosphorylated proteins. |
Accessions | Q13882 ENST00000542869.3 [Q13882-1] ENST00000217185.3 [Q13882-2] |